Norwegian medical technology company Lifecare signs lease agreement for LAB 1

The ink has dried: by signing up as the first tenant at the new biotechnology and life sciences hub, Norwegian medical device company Lifecare is setting a historic milestone in the development of this new science and business park in the state capital of Rhineland–Palatinate. Innovationspark Mainz GmbH & Co. KG (a joint venture of J. Molitor Immobilien GmbH, G.L. Kayser Immobilien GmbH and IGM Immobilien Gesellschaft Mainz mbh) welcomed Lifecare’s senior executives, who had travelled from Norway to sign the contract at the future scene of the action: on the building site for the first laboratory and office building, LAB 1.

LAB 1 is being built at the entrance to Mainz, in the immediate vicinity of Johannes Gutenberg University Mainz and Mainz University of Applied Sciences. Lifecare will lease around 1,000 square metres on the ground floor of the building. The Bergen-based company specialises in implantable microsensors using nanotechnology – e.g. for measuring blood sugar. Lifecare plans to move into the ground floor of LAB 1 in summer 2025, meaning that a third of the space in the first building, LAB 1, has already been reserved.

Representatives of Lifecare at the press event:
Joacim Holter, CEO of Lifecare AS
Professor Andreas Pfützner, CSO of Lifecare AS
Asle Wingsternes, Head of Communications & Public Affairs at Lifecare AS

Representatives of Innovationspark Mainz GmbH & Co. KG at the press event:
Tina Badrot and F. Albrecht Graf von Pfeil, both Managing Directors of J. Molitor Immobilien GmbH
Edmund Schmitz, Managing Director of G.L. Kayser Immobilien GmbH
Uwe Borgmann, Managing Director of IGM Immobilien Gesellschaft Mainz mbh